Milan, Italy

Francesco Boccalatte

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesco Boccalatte: Innovator in Genetic Modification

Introduction

Francesco Boccalatte is a notable inventor based in Milan, Italy. He has made significant contributions to the field of genetic modification, particularly in the area of stem cell therapy. His innovative methods have the potential to advance clinical applications in regenerative medicine.

Latest Patents

Francesco Boccalatte holds a patent for "Methods for genetic modification of stem cells." This patent describes a method of preparing a therapeutic cell population for clinical use from a starting population of cells comprising haematopoietic stem cells. The method involves separating a population of cells that substantially do not express CD38 but do express CD34 from the starting population of cells. The separated cell population is then transduced with a vector to obtain the therapeutic cell population. He has 1 patent to his name.

Career Highlights

Throughout his career, Francesco has worked with esteemed organizations such as Ospedale San Raffaele S.r.l. and Fondazione Telethon. His work in these institutions has allowed him to contribute to groundbreaking research in the field of genetics and stem cell therapy.

Collaborations

Francesco has collaborated with prominent figures in the field, including Luigi Naldini and Bernhard Rudolf Gentner. These collaborations have further enriched his research and innovation efforts.

Conclusion

Francesco Boccalatte's work in genetic modification of stem cells represents a significant advancement in therapeutic applications. His contributions continue to influence the field of regenerative medicine and highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…